Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 61 | 2021 | 11341 | 3.460 |
Why?
|
Prostate | 23 | 2020 | 1793 | 2.930 |
Why?
|
Urinary Bladder Neoplasms | 26 | 2020 | 2277 | 2.820 |
Why?
|
Kidney Neoplasms | 21 | 2020 | 4312 | 2.190 |
Why?
|
Prostatectomy | 16 | 2019 | 1956 | 1.850 |
Why?
|
Carcinoma, Renal Cell | 16 | 2020 | 3217 | 1.790 |
Why?
|
Urinary Bladder | 7 | 2019 | 1166 | 1.290 |
Why?
|
Urogenital Neoplasms | 2 | 2020 | 135 | 1.150 |
Why?
|
Adenocarcinoma | 17 | 2020 | 6310 | 1.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 19 | 2020 | 8498 | 1.080 |
Why?
|
Urethral Neoplasms | 2 | 2020 | 37 | 1.080 |
Why?
|
Carcinoma, Transitional Cell | 7 | 2019 | 800 | 1.000 |
Why?
|
Cystectomy | 7 | 2019 | 697 | 0.960 |
Why?
|
Prognosis | 43 | 2020 | 29636 | 0.900 |
Why?
|
Prostate-Specific Antigen | 15 | 2019 | 2528 | 0.900 |
Why?
|
Neoplasm Staging | 14 | 2020 | 11141 | 0.880 |
Why?
|
Occupational Therapy | 2 | 2023 | 139 | 0.850 |
Why?
|
MicroRNAs | 7 | 2019 | 3784 | 0.800 |
Why?
|
Disease Progression | 21 | 2019 | 13505 | 0.690 |
Why?
|
Aromatase | 3 | 2020 | 147 | 0.660 |
Why?
|
Prostatic Hyperplasia | 9 | 2020 | 531 | 0.640 |
Why?
|
Succinate Dehydrogenase | 2 | 2018 | 145 | 0.610 |
Why?
|
Activities of Daily Living | 6 | 2022 | 2414 | 0.610 |
Why?
|
Cushing Syndrome | 3 | 2010 | 242 | 0.600 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 5 | 2020 | 70 | 0.600 |
Why?
|
Calcium Signaling | 3 | 2019 | 731 | 0.600 |
Why?
|
Proto-Oncogene Proteins c-jun | 2 | 2017 | 285 | 0.600 |
Why?
|
Adenoma, Oxyphilic | 2 | 2020 | 148 | 0.600 |
Why?
|
Male | 136 | 2021 | 359413 | 0.590 |
Why?
|
Myosin-Light-Chain Phosphatase | 1 | 2017 | 20 | 0.580 |
Why?
|
Neoplasm Invasiveness | 15 | 2021 | 3618 | 0.570 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 2017 | 89 | 0.570 |
Why?
|
Physical Therapy Modalities | 5 | 2019 | 536 | 0.570 |
Why?
|
Hydrogen | 1 | 2017 | 171 | 0.550 |
Why?
|
Immunohistochemistry | 15 | 2019 | 11064 | 0.540 |
Why?
|
Magnetic Resonance Spectroscopy | 10 | 2019 | 3764 | 0.540 |
Why?
|
Biopsy | 11 | 2019 | 6775 | 0.510 |
Why?
|
Keratinocytes | 4 | 2019 | 792 | 0.500 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2015 | 101 | 0.500 |
Why?
|
Neoplasm Recurrence, Local | 11 | 2018 | 9274 | 0.500 |
Why?
|
Disulfides | 1 | 2017 | 466 | 0.490 |
Why?
|
Scleroderma, Systemic | 1 | 2019 | 344 | 0.490 |
Why?
|
Apoptosis | 12 | 2020 | 9497 | 0.490 |
Why?
|
Hematuria | 2 | 2013 | 233 | 0.480 |
Why?
|
Humans | 169 | 2023 | 760261 | 0.470 |
Why?
|
Adrenal Cortex Neoplasms | 2 | 2006 | 160 | 0.470 |
Why?
|
Lymphatic Metastasis | 3 | 2020 | 2945 | 0.460 |
Why?
|
Muscle, Smooth | 3 | 2016 | 924 | 0.450 |
Why?
|
Aged | 66 | 2022 | 168995 | 0.440 |
Why?
|
Middle Aged | 73 | 2021 | 220175 | 0.440 |
Why?
|
Cell Proliferation | 18 | 2020 | 10434 | 0.440 |
Why?
|
Cadmium | 2 | 2013 | 215 | 0.430 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2018 | 1135 | 0.430 |
Why?
|
Ultrasonography, Interventional | 1 | 2021 | 1503 | 0.430 |
Why?
|
Carcinoma, Ductal | 1 | 2013 | 98 | 0.430 |
Why?
|
Metabolomics | 6 | 2019 | 1626 | 0.420 |
Why?
|
Upper Extremity | 5 | 2019 | 661 | 0.410 |
Why?
|
Taiwan | 9 | 2020 | 503 | 0.410 |
Why?
|
RNA Interference | 5 | 2017 | 2846 | 0.410 |
Why?
|
Penile Neoplasms | 1 | 2014 | 162 | 0.400 |
Why?
|
Urothelium | 3 | 2020 | 277 | 0.400 |
Why?
|
Carcinoma, Small Cell | 2 | 2015 | 416 | 0.390 |
Why?
|
Cell Line, Tumor | 21 | 2020 | 16905 | 0.390 |
Why?
|
Survival Rate | 13 | 2020 | 12806 | 0.390 |
Why?
|
Disease-Free Survival | 11 | 2019 | 6830 | 0.390 |
Why?
|
Angiomyolipoma | 4 | 2020 | 184 | 0.380 |
Why?
|
Racemases and Epimerases | 4 | 2004 | 112 | 0.380 |
Why?
|
Kaplan-Meier Estimate | 12 | 2018 | 6545 | 0.380 |
Why?
|
Diagnosis, Differential | 12 | 2020 | 12968 | 0.380 |
Why?
|
Urethra | 2 | 2016 | 406 | 0.380 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2017 | 3483 | 0.370 |
Why?
|
Stroke | 11 | 2019 | 9945 | 0.370 |
Why?
|
Receptors, Androgen | 8 | 2018 | 1075 | 0.360 |
Why?
|
Lymphangioleiomyomatosis | 3 | 2019 | 203 | 0.360 |
Why?
|
Reactive Oxygen Species | 8 | 2020 | 2138 | 0.350 |
Why?
|
Membrane Proteins | 6 | 2020 | 7854 | 0.350 |
Why?
|
Movement | 1 | 2017 | 1474 | 0.340 |
Why?
|
Oxidative Stress | 4 | 2018 | 3107 | 0.340 |
Why?
|
Dermatitis, Atopic | 1 | 2017 | 710 | 0.340 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2015 | 728 | 0.340 |
Why?
|
Tuberous Sclerosis | 2 | 2014 | 1030 | 0.330 |
Why?
|
Microfilament Proteins | 1 | 2015 | 1134 | 0.330 |
Why?
|
Osteoporosis | 2 | 2017 | 1600 | 0.330 |
Why?
|
DNA Methylation | 9 | 2020 | 4374 | 0.330 |
Why?
|
Leuprolide | 1 | 2011 | 315 | 0.330 |
Why?
|
Neovascularization, Pathologic | 2 | 2017 | 2641 | 0.330 |
Why?
|
Genes, Tumor Suppressor | 1 | 2014 | 1056 | 0.330 |
Why?
|
Paresis | 4 | 2019 | 177 | 0.330 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2015 | 1109 | 0.330 |
Why?
|
Cell Movement | 8 | 2018 | 5206 | 0.330 |
Why?
|
Tumor Suppressor Proteins | 7 | 2016 | 2804 | 0.320 |
Why?
|
Ureteral Neoplasms | 1 | 2009 | 110 | 0.310 |
Why?
|
Feedback, Sensory | 2 | 2019 | 56 | 0.310 |
Why?
|
Neoplastic Cells, Circulating | 5 | 2018 | 938 | 0.310 |
Why?
|
Kidney Pelvis | 1 | 2009 | 188 | 0.310 |
Why?
|
Paraneoplastic Syndromes | 1 | 2010 | 155 | 0.310 |
Why?
|
RNA, Messenger | 13 | 2020 | 12762 | 0.310 |
Why?
|
Acetyltransferases | 2 | 2010 | 231 | 0.310 |
Why?
|
Tumor Microenvironment | 2 | 2019 | 3826 | 0.310 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2020 | 412 | 0.300 |
Why?
|
Androstenes | 2 | 2020 | 179 | 0.290 |
Why?
|
Stromal Cells | 5 | 2020 | 1327 | 0.280 |
Why?
|
Laparoscopy | 3 | 2013 | 2155 | 0.280 |
Why?
|
Proportional Hazards Models | 9 | 2018 | 12532 | 0.280 |
Why?
|
Dextromethorphan | 1 | 2006 | 37 | 0.280 |
Why?
|
Cyclins | 3 | 2007 | 593 | 0.280 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2011 | 549 | 0.280 |
Why?
|
Hysterectomy, Vaginal | 1 | 2006 | 38 | 0.280 |
Why?
|
Androgen Antagonists | 3 | 2015 | 1439 | 0.280 |
Why?
|
Ureter | 1 | 2009 | 375 | 0.280 |
Why?
|
Signal Transduction | 16 | 2019 | 23363 | 0.270 |
Why?
|
Diagnostic Imaging | 5 | 2018 | 3526 | 0.270 |
Why?
|
Neoplasm Metastasis | 7 | 2019 | 4891 | 0.270 |
Why?
|
Tissue Array Analysis | 3 | 2018 | 551 | 0.260 |
Why?
|
Ketorolac | 1 | 2006 | 94 | 0.260 |
Why?
|
Bone Neoplasms | 3 | 2019 | 2532 | 0.260 |
Why?
|
Adrenocortical Carcinoma | 1 | 2006 | 87 | 0.260 |
Why?
|
Gastroenteritis | 2 | 2020 | 237 | 0.260 |
Why?
|
Anemia | 1 | 2015 | 1511 | 0.250 |
Why?
|
Female | 68 | 2020 | 391011 | 0.250 |
Why?
|
Nuclear Receptor Coactivators | 2 | 2017 | 61 | 0.250 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4554 | 0.250 |
Why?
|
Kidney | 3 | 2018 | 7072 | 0.250 |
Why?
|
Adrenocortical Adenoma | 1 | 2005 | 46 | 0.240 |
Why?
|
Stevens-Johnson Syndrome | 2 | 2018 | 244 | 0.240 |
Why?
|
Movement Disorders | 1 | 2008 | 459 | 0.240 |
Why?
|
Retrospective Studies | 25 | 2023 | 80301 | 0.240 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2006 | 255 | 0.230 |
Why?
|
Radiation Injuries | 2 | 2016 | 1183 | 0.230 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2004 | 81 | 0.230 |
Why?
|
Aged, 80 and over | 23 | 2020 | 58947 | 0.230 |
Why?
|
Gene Expression Profiling | 9 | 2019 | 9388 | 0.230 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2018 | 3584 | 0.230 |
Why?
|
Incidental Findings | 2 | 2019 | 698 | 0.230 |
Why?
|
5-alpha Reductase Inhibitors | 2 | 2020 | 117 | 0.230 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2874 | 0.220 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2009 | 656 | 0.220 |
Why?
|
Adult | 41 | 2020 | 219847 | 0.220 |
Why?
|
Brachytherapy | 1 | 2011 | 1240 | 0.220 |
Why?
|
Pheochromocytoma | 1 | 2005 | 328 | 0.210 |
Why?
|
Urologic Neoplasms | 2 | 2020 | 321 | 0.210 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2011 | 1523 | 0.210 |
Why?
|
Cadherins | 3 | 2017 | 898 | 0.210 |
Why?
|
Survival Analysis | 5 | 2019 | 10185 | 0.210 |
Why?
|
Carcinoma, Papillary | 2 | 2020 | 785 | 0.210 |
Why?
|
Adrenal Glands | 1 | 2005 | 556 | 0.200 |
Why?
|
Parotid Diseases | 1 | 2002 | 49 | 0.200 |
Why?
|
Histiocytosis, Sinus | 1 | 2002 | 46 | 0.200 |
Why?
|
Cell Cycle | 4 | 2018 | 2937 | 0.200 |
Why?
|
Telepathology | 2 | 2014 | 77 | 0.200 |
Why?
|
Mass Spectrometry | 3 | 2017 | 2192 | 0.200 |
Why?
|
Lymphoproliferative Disorders | 2 | 2002 | 533 | 0.190 |
Why?
|
Multivariate Analysis | 6 | 2019 | 12156 | 0.190 |
Why?
|
Disability Evaluation | 6 | 2020 | 1826 | 0.190 |
Why?
|
Immunoenzyme Techniques | 5 | 2014 | 1705 | 0.190 |
Why?
|
Chemotherapy, Adjuvant | 7 | 2019 | 3531 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2015 | 2449 | 0.190 |
Why?
|
Postural Balance | 2 | 2020 | 617 | 0.180 |
Why?
|
Receptors, CCR8 | 1 | 2020 | 28 | 0.180 |
Why?
|
Risk Assessment | 4 | 2018 | 24086 | 0.180 |
Why?
|
Time and Motion Studies | 1 | 2020 | 143 | 0.180 |
Why?
|
Glycerolphosphate Dehydrogenase | 1 | 2020 | 37 | 0.180 |
Why?
|
Alternative Splicing | 1 | 2005 | 1091 | 0.180 |
Why?
|
Tumor Burden | 3 | 2015 | 1897 | 0.180 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2020 | 38 | 0.180 |
Why?
|
Glycerophosphates | 1 | 2020 | 47 | 0.180 |
Why?
|
Home Health Aides | 1 | 2020 | 16 | 0.180 |
Why?
|
Caliciviridae Infections | 1 | 2020 | 29 | 0.170 |
Why?
|
Metformin | 2 | 2020 | 912 | 0.170 |
Why?
|
Norovirus | 1 | 2020 | 36 | 0.170 |
Why?
|
Remote Consultation | 2 | 2014 | 234 | 0.170 |
Why?
|
Loss of Heterozygosity | 5 | 2016 | 659 | 0.170 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2005 | 734 | 0.170 |
Why?
|
COUP Transcription Factor II | 1 | 2019 | 18 | 0.170 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2015 | 4024 | 0.170 |
Why?
|
Watchful Waiting | 2 | 2015 | 510 | 0.170 |
Why?
|
Promoter Regions, Genetic | 8 | 2020 | 5784 | 0.170 |
Why?
|
Phosphoproteins | 2 | 2005 | 2441 | 0.170 |
Why?
|
TRPC Cation Channels | 1 | 2019 | 110 | 0.170 |
Why?
|
Spermatocele | 1 | 2018 | 10 | 0.160 |
Why?
|
Chemokines, CC | 1 | 2020 | 283 | 0.160 |
Why?
|
Exercise Therapy | 3 | 2017 | 920 | 0.160 |
Why?
|
Lactate Dehydrogenases | 1 | 2018 | 27 | 0.160 |
Why?
|
Pathology, Clinical | 2 | 2014 | 375 | 0.160 |
Why?
|
Colonic Neoplasms | 2 | 2013 | 2526 | 0.160 |
Why?
|
Estradiol | 2 | 2017 | 1932 | 0.160 |
Why?
|
Hemangiopericytoma | 1 | 2018 | 71 | 0.160 |
Why?
|
Hyphae | 1 | 2018 | 52 | 0.160 |
Why?
|
Indomethacin | 1 | 2019 | 326 | 0.160 |
Why?
|
Cryopreservation | 1 | 2003 | 720 | 0.160 |
Why?
|
Treatment Outcome | 18 | 2020 | 64947 | 0.150 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 4573 | 0.150 |
Why?
|
Varicocele | 1 | 2018 | 78 | 0.150 |
Why?
|
Tumor Cells, Cultured | 6 | 2020 | 6131 | 0.150 |
Why?
|
Robotics | 2 | 2019 | 880 | 0.150 |
Why?
|
Cell Dedifferentiation | 1 | 2019 | 122 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 5 | 2021 | 36247 | 0.150 |
Why?
|
Skin Aging | 1 | 2019 | 141 | 0.150 |
Why?
|
Mice, Nude | 7 | 2020 | 3605 | 0.150 |
Why?
|
Gastrointestinal Diseases | 1 | 2016 | 1189 | 0.150 |
Why?
|
gamma-Glutamyltransferase | 1 | 2018 | 144 | 0.150 |
Why?
|
RNA-Binding Protein EWS | 1 | 2019 | 210 | 0.150 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2018 | 2927 | 0.150 |
Why?
|
Hypertension | 3 | 2010 | 8595 | 0.150 |
Why?
|
Restraint, Physical | 2 | 2010 | 186 | 0.150 |
Why?
|
Follow-Up Studies | 11 | 2018 | 39254 | 0.150 |
Why?
|
Gene Amplification | 2 | 2013 | 1085 | 0.150 |
Why?
|
Estrogen Receptor alpha | 2 | 2019 | 580 | 0.150 |
Why?
|
BK Virus | 1 | 2018 | 124 | 0.150 |
Why?
|
Boron Compounds | 1 | 2019 | 180 | 0.150 |
Why?
|
Transcription Factors | 4 | 2011 | 12100 | 0.140 |
Why?
|
Boston | 6 | 2017 | 9282 | 0.140 |
Why?
|
Age Factors | 6 | 2017 | 18415 | 0.140 |
Why?
|
Carrier Proteins | 4 | 2014 | 4938 | 0.140 |
Why?
|
Transients and Migrants | 1 | 2020 | 162 | 0.140 |
Why?
|
Blotting, Western | 6 | 2014 | 5039 | 0.140 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 256 | 0.140 |
Why?
|
Prolactin | 1 | 2019 | 621 | 0.140 |
Why?
|
Cell Growth Processes | 3 | 2020 | 384 | 0.140 |
Why?
|
STAT3 Transcription Factor | 2 | 2019 | 877 | 0.140 |
Why?
|
PPAR gamma | 2 | 2017 | 484 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2019 | 11708 | 0.140 |
Why?
|
beta-Globins | 1 | 2017 | 108 | 0.140 |
Why?
|
Liver Neoplasms | 4 | 2017 | 4317 | 0.130 |
Why?
|
Sirtuin 1 | 1 | 2017 | 247 | 0.130 |
Why?
|
Polyomavirus Infections | 1 | 2018 | 195 | 0.130 |
Why?
|
TRPM Cation Channels | 1 | 2017 | 139 | 0.130 |
Why?
|
Pain, Postoperative | 1 | 2006 | 1718 | 0.130 |
Why?
|
Base Sequence | 3 | 2019 | 12447 | 0.130 |
Why?
|
Endometrial Neoplasms | 1 | 2005 | 1361 | 0.130 |
Why?
|
Caspase 12 | 1 | 2015 | 8 | 0.130 |
Why?
|
Mice | 20 | 2020 | 81216 | 0.130 |
Why?
|
Cerebral Palsy | 2 | 2011 | 471 | 0.130 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2018 | 345 | 0.130 |
Why?
|
Animals | 29 | 2020 | 167940 | 0.130 |
Why?
|
Carbamazepine | 1 | 2016 | 224 | 0.130 |
Why?
|
Leukocyte Disorders | 1 | 2015 | 13 | 0.130 |
Why?
|
Drug Labeling | 1 | 2018 | 251 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2018 | 730 | 0.130 |
Why?
|
Candidiasis | 1 | 2018 | 364 | 0.130 |
Why?
|
Pathology, Surgical | 2 | 2014 | 151 | 0.130 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3613 | 0.130 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 454 | 0.130 |
Why?
|
Reproducibility of Results | 8 | 2020 | 20048 | 0.130 |
Why?
|
Transcription Factor CHOP | 1 | 2015 | 68 | 0.130 |
Why?
|
GTPase-Activating Proteins | 1 | 2019 | 475 | 0.130 |
Why?
|
Calcium Channel Blockers | 1 | 2019 | 694 | 0.130 |
Why?
|
Granuloma, Pyogenic | 1 | 2015 | 47 | 0.130 |
Why?
|
HLA-B Antigens | 1 | 2016 | 331 | 0.130 |
Why?
|
Phthalazines | 1 | 2018 | 377 | 0.130 |
Why?
|
Candida albicans | 1 | 2018 | 378 | 0.130 |
Why?
|
Recovery of Function | 6 | 2019 | 2982 | 0.120 |
Why?
|
Dansyl Compounds | 1 | 2014 | 20 | 0.120 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2019 | 613 | 0.120 |
Why?
|
bcl-Associated Death Protein | 1 | 2015 | 102 | 0.120 |
Why?
|
Testis | 1 | 2018 | 794 | 0.120 |
Why?
|
Hydrocortisone | 3 | 2010 | 1798 | 0.120 |
Why?
|
ROC Curve | 4 | 2019 | 3568 | 0.120 |
Why?
|
Turbinates | 1 | 2015 | 64 | 0.120 |
Why?
|
Cognition | 3 | 2023 | 6948 | 0.120 |
Why?
|
Nose Diseases | 1 | 2015 | 79 | 0.120 |
Why?
|
RNA, Neoplasm | 1 | 2018 | 749 | 0.120 |
Why?
|
Sex Factors | 3 | 2018 | 10530 | 0.120 |
Why?
|
Time Factors | 11 | 2019 | 40133 | 0.120 |
Why?
|
Radionuclide Imaging | 2 | 2012 | 1975 | 0.120 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2019 | 346 | 0.120 |
Why?
|
In Situ Hybridization | 3 | 2016 | 1900 | 0.120 |
Why?
|
Rotavirus Vaccines | 1 | 2015 | 63 | 0.120 |
Why?
|
Neurofibromin 1 | 1 | 2016 | 190 | 0.120 |
Why?
|
Adenosine Triphosphate | 2 | 2020 | 1995 | 0.120 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 620 | 0.120 |
Why?
|
Imidazoles | 2 | 2019 | 1178 | 0.120 |
Why?
|
Protective Agents | 1 | 2015 | 150 | 0.120 |
Why?
|
Disease Models, Animal | 7 | 2020 | 18134 | 0.120 |
Why?
|
Androgens | 2 | 2020 | 1289 | 0.120 |
Why?
|
Herpesvirus 1, Human | 2 | 2010 | 753 | 0.120 |
Why?
|
Principal Component Analysis | 3 | 2019 | 939 | 0.120 |
Why?
|
Rotavirus Infections | 1 | 2015 | 86 | 0.120 |
Why?
|
Cyclopentanes | 1 | 2014 | 89 | 0.120 |
Why?
|
In Situ Nick-End Labeling | 1 | 2015 | 613 | 0.120 |
Why?
|
Rotavirus | 1 | 2015 | 111 | 0.120 |
Why?
|
Proteus mirabilis | 1 | 2014 | 25 | 0.120 |
Why?
|
Gene Rearrangement | 1 | 2019 | 1122 | 0.120 |
Why?
|
Deoxycytidine | 1 | 2018 | 872 | 0.120 |
Why?
|
Fungal Proteins | 1 | 2018 | 911 | 0.120 |
Why?
|
Single-Blind Method | 4 | 2019 | 1577 | 0.120 |
Why?
|
Poland | 1 | 2014 | 196 | 0.120 |
Why?
|
Telangiectasis | 1 | 2014 | 77 | 0.110 |
Why?
|
SEER Program | 1 | 2019 | 1532 | 0.110 |
Why?
|
Risk Factors | 13 | 2020 | 74269 | 0.110 |
Why?
|
Cytoskeleton | 1 | 2019 | 1167 | 0.110 |
Why?
|
Cystitis | 1 | 2014 | 96 | 0.110 |
Why?
|
Phenylthiohydantoin | 1 | 2015 | 203 | 0.110 |
Why?
|
Transfection | 5 | 2017 | 5782 | 0.110 |
Why?
|
Aromatase Inhibitors | 1 | 2018 | 511 | 0.110 |
Why?
|
Mice, Inbred BALB C | 6 | 2020 | 6226 | 0.110 |
Why?
|
Musculoskeletal Diseases | 1 | 2020 | 594 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor B | 1 | 2013 | 26 | 0.110 |
Why?
|
Hydrogen Peroxide | 1 | 2017 | 732 | 0.110 |
Why?
|
Incidence | 4 | 2017 | 21378 | 0.110 |
Why?
|
Mitochondria | 4 | 2020 | 3598 | 0.110 |
Why?
|
Skin | 2 | 2019 | 4468 | 0.110 |
Why?
|
Students | 1 | 2023 | 1722 | 0.110 |
Why?
|
Predictive Value of Tests | 7 | 2017 | 15273 | 0.110 |
Why?
|
Carcinoma | 2 | 2016 | 2334 | 0.110 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 987 | 0.110 |
Why?
|
Models, Anatomic | 1 | 2017 | 682 | 0.110 |
Why?
|
Antigens, Surface | 1 | 2017 | 1616 | 0.110 |
Why?
|
Posterior Horn Cells | 1 | 2013 | 90 | 0.110 |
Why?
|
Magnetoencephalography | 1 | 2017 | 634 | 0.110 |
Why?
|
Combined Modality Therapy | 6 | 2017 | 8551 | 0.110 |
Why?
|
Sciatica | 1 | 2013 | 97 | 0.110 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2017 | 1173 | 0.110 |
Why?
|
Chromatography, Micellar Electrokinetic Capillary | 1 | 2012 | 3 | 0.110 |
Why?
|
Estrogens | 1 | 2020 | 1520 | 0.110 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2013 | 59 | 0.110 |
Why?
|
Fibroblasts | 3 | 2019 | 4091 | 0.110 |
Why?
|
3' Untranslated Regions | 1 | 2015 | 514 | 0.110 |
Why?
|
Cohort Studies | 9 | 2021 | 41317 | 0.110 |
Why?
|
Ultrasonography | 4 | 2018 | 5960 | 0.110 |
Why?
|
Translocation, Genetic | 1 | 2018 | 1388 | 0.110 |
Why?
|
Polymethacrylic Acids | 1 | 2012 | 32 | 0.110 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2015 | 462 | 0.110 |
Why?
|
Preoperative Period | 1 | 2015 | 555 | 0.110 |
Why?
|
Penis | 1 | 2014 | 212 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 256 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2017 | 2297 | 0.100 |
Why?
|
Prostaglandins | 1 | 2014 | 398 | 0.100 |
Why?
|
Oncogenes | 1 | 2018 | 1221 | 0.100 |
Why?
|
Dinoprostone | 2 | 2019 | 599 | 0.100 |
Why?
|
Oligopeptides | 1 | 2018 | 1188 | 0.100 |
Why?
|
Pregnancy Complications | 1 | 2006 | 2940 | 0.100 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2019 | 2500 | 0.100 |
Why?
|
Preoperative Care | 2 | 2015 | 2255 | 0.100 |
Why?
|
Cyclooxygenase 2 | 4 | 2019 | 600 | 0.100 |
Why?
|
Phylogeny | 1 | 2020 | 2775 | 0.100 |
Why?
|
Ischemic Attack, Transient | 1 | 2018 | 899 | 0.100 |
Why?
|
Muscle Neoplasms | 1 | 2013 | 133 | 0.100 |
Why?
|
Mutation | 10 | 2018 | 29950 | 0.100 |
Why?
|
Laser Coagulation | 1 | 2014 | 327 | 0.100 |
Why?
|
Neoplasms, Hormone-Dependent | 2 | 2012 | 412 | 0.100 |
Why?
|
Down-Regulation | 5 | 2019 | 2918 | 0.100 |
Why?
|
Lasers, Solid-State | 1 | 2014 | 175 | 0.100 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2015 | 633 | 0.100 |
Why?
|
Haploinsufficiency | 1 | 2013 | 329 | 0.100 |
Why?
|
Polyvinyls | 1 | 2012 | 154 | 0.100 |
Why?
|
Bowen's Disease | 1 | 2011 | 13 | 0.100 |
Why?
|
Heat-Shock Proteins | 1 | 2015 | 795 | 0.100 |
Why?
|
Leukocyte Count | 1 | 2015 | 1600 | 0.100 |
Why?
|
Cholestenone 5 alpha-Reductase | 1 | 2011 | 21 | 0.100 |
Why?
|
Wnt Proteins | 1 | 2015 | 718 | 0.100 |
Why?
|
Forkhead Transcription Factors | 1 | 2018 | 1613 | 0.090 |
Why?
|
Calcium | 4 | 2019 | 5726 | 0.090 |
Why?
|
Motor Activity | 2 | 2019 | 2687 | 0.090 |
Why?
|
Arsenic Poisoning | 1 | 2011 | 55 | 0.090 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2013 | 444 | 0.090 |
Why?
|
Naloxone | 1 | 2013 | 369 | 0.090 |
Why?
|
Psychometrics | 1 | 2020 | 3049 | 0.090 |
Why?
|
Recurrence | 3 | 2014 | 8487 | 0.090 |
Why?
|
Nephrectomy | 3 | 2017 | 1017 | 0.090 |
Why?
|
Dilazep | 1 | 2010 | 4 | 0.090 |
Why?
|
Pituitary Gland, Anterior | 1 | 2010 | 142 | 0.090 |
Why?
|
Areca | 1 | 2010 | 11 | 0.090 |
Why?
|
Collagen | 1 | 2019 | 2635 | 0.090 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2010 | 17 | 0.090 |
Why?
|
Statistics, Nonparametric | 4 | 2018 | 2852 | 0.090 |
Why?
|
Ornithine Decarboxylase | 1 | 2010 | 64 | 0.090 |
Why?
|
Ribs | 1 | 2012 | 254 | 0.090 |
Why?
|
Anticonvulsants | 2 | 2018 | 1881 | 0.090 |
Why?
|
Spermine | 1 | 2010 | 69 | 0.090 |
Why?
|
Cells, Cultured | 5 | 2019 | 18968 | 0.090 |
Why?
|
Molecular Imaging | 1 | 2017 | 817 | 0.090 |
Why?
|
Neutrophils | 2 | 2015 | 3770 | 0.090 |
Why?
|
Diabetes Insipidus | 1 | 2010 | 144 | 0.090 |
Why?
|
Dipyridamole | 1 | 2010 | 143 | 0.090 |
Why?
|
Case-Control Studies | 7 | 2019 | 22041 | 0.090 |
Why?
|
Motor Cortex | 1 | 2017 | 995 | 0.090 |
Why?
|
Ultrasonics | 1 | 2011 | 207 | 0.090 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1675 | 0.090 |
Why?
|
Multiprotein Complexes | 2 | 2014 | 1120 | 0.090 |
Why?
|
Lung Neoplasms | 5 | 2019 | 13249 | 0.080 |
Why?
|
Pain Threshold | 1 | 2013 | 600 | 0.080 |
Why?
|
Electric Stimulation Therapy | 1 | 2015 | 613 | 0.080 |
Why?
|
Motor Skills | 2 | 2015 | 520 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1892 | 0.080 |
Why?
|
Glucose Intolerance | 1 | 2013 | 579 | 0.080 |
Why?
|
Physical Fitness | 2 | 2011 | 732 | 0.080 |
Why?
|
Obesity | 3 | 2020 | 12915 | 0.080 |
Why?
|
Cystatin B | 1 | 2009 | 12 | 0.080 |
Why?
|
Endoplasmic Reticulum | 1 | 2015 | 1135 | 0.080 |
Why?
|
Morphine | 1 | 2013 | 656 | 0.080 |
Why?
|
Adenoma | 1 | 2020 | 2148 | 0.080 |
Why?
|
Hyperalgesia | 1 | 2013 | 530 | 0.080 |
Why?
|
Penicillins | 1 | 2012 | 403 | 0.080 |
Why?
|
Protein Conformation | 1 | 2017 | 3969 | 0.080 |
Why?
|
Phosphorylation | 7 | 2017 | 8314 | 0.080 |
Why?
|
Caenorhabditis elegans | 1 | 2018 | 1444 | 0.080 |
Why?
|
Quinolines | 1 | 2014 | 759 | 0.080 |
Why?
|
Visual Perception | 1 | 2017 | 1374 | 0.080 |
Why?
|
Arm | 2 | 2010 | 583 | 0.080 |
Why?
|
Adenine | 1 | 2014 | 976 | 0.080 |
Why?
|
Narcotic Antagonists | 1 | 2013 | 582 | 0.080 |
Why?
|
Cell Survival | 5 | 2018 | 5796 | 0.080 |
Why?
|
Hypopituitarism | 1 | 2010 | 248 | 0.080 |
Why?
|
Antigens, CD | 2 | 2017 | 4002 | 0.080 |
Why?
|
Adipocytes | 2 | 2020 | 1179 | 0.080 |
Why?
|
Diabetes Complications | 1 | 2015 | 1342 | 0.080 |
Why?
|
Young Adult | 11 | 2019 | 58673 | 0.080 |
Why?
|
China | 1 | 2014 | 2340 | 0.080 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 13629 | 0.080 |
Why?
|
Colonic Polyps | 1 | 2013 | 550 | 0.080 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2010 | 438 | 0.080 |
Why?
|
Epigenesis, Genetic | 2 | 2020 | 3758 | 0.080 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2010 | 619 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2017 | 1870 | 0.070 |
Why?
|
Pituitary Gland | 1 | 2010 | 637 | 0.070 |
Why?
|
Muscle Spasticity | 1 | 2008 | 155 | 0.070 |
Why?
|
Bone Density | 2 | 2011 | 3528 | 0.070 |
Why?
|
Lymphocytes | 1 | 2015 | 2612 | 0.070 |
Why?
|
Skull | 1 | 2012 | 815 | 0.070 |
Why?
|
Urinary Retention | 1 | 2008 | 107 | 0.070 |
Why?
|
Piperazines | 1 | 2018 | 2520 | 0.070 |
Why?
|
Kidney Transplantation | 2 | 2018 | 4215 | 0.070 |
Why?
|
Finasteride | 1 | 2008 | 90 | 0.070 |
Why?
|
Psychomotor Performance | 1 | 2015 | 1876 | 0.070 |
Why?
|
Cisplatin | 4 | 2018 | 1642 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2014 | 2058 | 0.070 |
Why?
|
Ileum | 1 | 2009 | 556 | 0.070 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2014 | 1244 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1534 | 0.070 |
Why?
|
Contrast Media | 1 | 2020 | 5301 | 0.070 |
Why?
|
Testosterone | 1 | 2017 | 2469 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3561 | 0.070 |
Why?
|
Organ Size | 1 | 2011 | 2249 | 0.070 |
Why?
|
Flow Cytometry | 2 | 2014 | 5873 | 0.070 |
Why?
|
Mobility Limitation | 1 | 2010 | 402 | 0.070 |
Why?
|
Autophagy | 1 | 2014 | 1336 | 0.070 |
Why?
|
Plant Extracts | 1 | 2010 | 495 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 934 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2019 | 2823 | 0.070 |
Why?
|
Binding Sites | 1 | 2015 | 6050 | 0.070 |
Why?
|
Quinazolines | 1 | 2013 | 1363 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2017 | 4357 | 0.070 |
Why?
|
Receptors, Estrogen | 1 | 2014 | 2202 | 0.070 |
Why?
|
Analysis of Variance | 5 | 2018 | 6242 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2014 | 20484 | 0.070 |
Why?
|
Anthropometry | 1 | 2011 | 1348 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2010 | 2866 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2019 | 3127 | 0.070 |
Why?
|
Pseudomonas aeruginosa | 1 | 2014 | 1275 | 0.070 |
Why?
|
United States | 5 | 2019 | 72363 | 0.060 |
Why?
|
Seizures | 1 | 2018 | 2916 | 0.060 |
Why?
|
Feedback, Physiological | 2 | 2019 | 476 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1483 | 0.060 |
Why?
|
Cell Respiration | 2 | 2020 | 202 | 0.060 |
Why?
|
Sirolimus | 1 | 2013 | 1548 | 0.060 |
Why?
|
Edema | 1 | 2010 | 772 | 0.060 |
Why?
|
19-Iodocholesterol | 1 | 2005 | 1 | 0.060 |
Why?
|
Tomography, Optical Coherence | 1 | 2018 | 2878 | 0.060 |
Why?
|
Afferent Pathways | 2 | 2017 | 299 | 0.060 |
Why?
|
HT29 Cells | 1 | 2005 | 190 | 0.060 |
Why?
|
Enuresis | 1 | 2005 | 50 | 0.060 |
Why?
|
Insulin-Secreting Cells | 1 | 2013 | 907 | 0.060 |
Why?
|
Curcumin | 1 | 2006 | 98 | 0.060 |
Why?
|
3T3-L1 Cells | 2 | 2020 | 209 | 0.060 |
Why?
|
Mitochondrial Proteins | 1 | 2011 | 979 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2010 | 1833 | 0.060 |
Why?
|
Gene Knockdown Techniques | 3 | 2017 | 1617 | 0.060 |
Why?
|
Up-Regulation | 3 | 2019 | 4127 | 0.060 |
Why?
|
Logistic Models | 3 | 2019 | 13311 | 0.060 |
Why?
|
Oncolytic Virotherapy | 1 | 2010 | 515 | 0.060 |
Why?
|
Sensitivity and Specificity | 4 | 2015 | 14656 | 0.060 |
Why?
|
Rats | 3 | 2015 | 23695 | 0.060 |
Why?
|
Analgesics, Opioid | 2 | 2013 | 3762 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 1 | 2015 | 8157 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2020 | 4440 | 0.060 |
Why?
|
Catecholamines | 1 | 2005 | 385 | 0.060 |
Why?
|
Cholesterol, HDL | 1 | 2011 | 1817 | 0.060 |
Why?
|
Adrenal Gland Diseases | 1 | 2005 | 141 | 0.060 |
Why?
|
Paclitaxel | 2 | 2016 | 1738 | 0.060 |
Why?
|
Pregnancy Trimester, Second | 1 | 2006 | 732 | 0.060 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 3443 | 0.060 |
Why?
|
Urination Disorders | 1 | 2005 | 241 | 0.060 |
Why?
|
Gene Deletion | 1 | 2011 | 2668 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2015 | 5230 | 0.060 |
Why?
|
Epithelial Cells | 3 | 2011 | 3665 | 0.060 |
Why?
|
Patient Readmission | 1 | 2018 | 3327 | 0.060 |
Why?
|
Blood Chemical Analysis | 1 | 2005 | 437 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2017 | 3976 | 0.050 |
Why?
|
Cyclooxygenase 2 Inhibitors | 2 | 2019 | 321 | 0.050 |
Why?
|
Computational Biology | 2 | 2019 | 3504 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2013 | 2283 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 2282 | 0.050 |
Why?
|
Drug Synergism | 2 | 2020 | 1755 | 0.050 |
Why?
|
Child | 8 | 2020 | 79758 | 0.050 |
Why?
|
Ultraviolet Rays | 2 | 2019 | 1078 | 0.050 |
Why?
|
Protein Isoforms | 2 | 2018 | 1697 | 0.050 |
Why?
|
Naphthyridines | 2 | 2014 | 141 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 25928 | 0.050 |
Why?
|
Protein Kinases | 1 | 2009 | 1612 | 0.050 |
Why?
|
Trail Making Test | 1 | 2022 | 57 | 0.050 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 2018 | 246 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 17628 | 0.050 |
Why?
|
Virus Replication | 1 | 2010 | 2431 | 0.050 |
Why?
|
Odds Ratio | 2 | 2012 | 9712 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3335 | 0.050 |
Why?
|
Cell Division | 1 | 2009 | 4462 | 0.050 |
Why?
|
DNA | 1 | 2015 | 7236 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2017 | 1439 | 0.050 |
Why?
|
Radiography | 2 | 2020 | 6965 | 0.050 |
Why?
|
Cholesterol | 1 | 2011 | 2925 | 0.050 |
Why?
|
Proteomics | 1 | 2015 | 3810 | 0.050 |
Why?
|
Isoenzymes | 2 | 2020 | 1690 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2019 | 3618 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2015 | 5248 | 0.050 |
Why?
|
Receptors, Virus | 1 | 2005 | 639 | 0.050 |
Why?
|
Sequence Deletion | 1 | 2005 | 1493 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2422 | 0.050 |
Why?
|
Phantoms, Imaging | 1 | 2010 | 2510 | 0.050 |
Why?
|
Neurofibromatoses | 1 | 2005 | 299 | 0.050 |
Why?
|
Fluorouracil | 2 | 2018 | 1630 | 0.050 |
Why?
|
Insulin | 3 | 2013 | 6592 | 0.050 |
Why?
|
RNA Splicing | 2 | 2016 | 914 | 0.050 |
Why?
|
Hyperglycemia | 1 | 2010 | 1380 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2010 | 3726 | 0.050 |
Why?
|
Patient Care Team | 1 | 2012 | 2510 | 0.050 |
Why?
|
Child, Preschool | 7 | 2020 | 42034 | 0.050 |
Why?
|
Drug Combinations | 1 | 2006 | 2024 | 0.050 |
Why?
|
Mice, SCID | 2 | 2017 | 2627 | 0.050 |
Why?
|
Patient Selection | 2 | 2012 | 4276 | 0.040 |
Why?
|
17-Hydroxycorticosteroids | 1 | 2020 | 39 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2018 | 7593 | 0.040 |
Why?
|
Moving and Lifting Patients | 1 | 2020 | 18 | 0.040 |
Why?
|
Adolescent | 7 | 2020 | 87747 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2011 | 2783 | 0.040 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2007 | 1920 | 0.040 |
Why?
|
Gene Regulatory Networks | 2 | 2018 | 1740 | 0.040 |
Why?
|
Neoplasms | 2 | 2020 | 22066 | 0.040 |
Why?
|
Transurethral Resection of Prostate | 1 | 2020 | 85 | 0.040 |
Why?
|
Retinoid X Receptors | 1 | 2019 | 91 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 402 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2019 | 67 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2013 | 616 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11902 | 0.040 |
Why?
|
Discriminant Analysis | 1 | 2019 | 223 | 0.040 |
Why?
|
Carcinogenicity Tests | 1 | 2018 | 38 | 0.040 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 688 | 0.040 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2019 | 232 | 0.040 |
Why?
|
Proteins | 2 | 2010 | 6030 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 2019 | 369 | 0.040 |
Why?
|
Vimentin | 1 | 2018 | 255 | 0.040 |
Why?
|
Colony Count, Microbial | 1 | 2018 | 328 | 0.040 |
Why?
|
Imitative Behavior | 1 | 2017 | 35 | 0.040 |
Why?
|
Nitriles | 2 | 2015 | 955 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2020 | 469 | 0.040 |
Why?
|
Phosphorus | 1 | 2019 | 335 | 0.040 |
Why?
|
Stroop Test | 1 | 2017 | 72 | 0.040 |
Why?
|
Cell Line | 3 | 2018 | 15626 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 2018 | 211 | 0.040 |
Why?
|
Transcriptional Activation | 2 | 2018 | 1755 | 0.040 |
Why?
|
Dihydrotestosterone | 1 | 2017 | 195 | 0.040 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2018 | 198 | 0.040 |
Why?
|
Headache | 1 | 2005 | 1249 | 0.040 |
Why?
|
Acute Disease | 2 | 2020 | 7268 | 0.040 |
Why?
|
Cell Transformation, Viral | 1 | 2018 | 526 | 0.040 |
Why?
|
Inflammation Mediators | 2 | 2020 | 1882 | 0.030 |
Why?
|
Allopurinol | 1 | 2018 | 200 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1655 | 0.030 |
Why?
|
Diabetes, Gestational | 1 | 2006 | 1241 | 0.030 |
Why?
|
RNA Probes | 1 | 2016 | 111 | 0.030 |
Why?
|
Kallikreins | 1 | 2018 | 231 | 0.030 |
Why?
|
Texas | 1 | 2017 | 401 | 0.030 |
Why?
|
Functional Laterality | 2 | 2017 | 2253 | 0.030 |
Why?
|
Cytoprotection | 1 | 2017 | 200 | 0.030 |
Why?
|
HLA-A Antigens | 1 | 2016 | 225 | 0.030 |
Why?
|
Protein Stability | 1 | 2018 | 566 | 0.030 |
Why?
|
Integrases | 1 | 2018 | 516 | 0.030 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2016 | 74 | 0.030 |
Why?
|
Thailand | 1 | 2016 | 289 | 0.030 |
Why?
|
Pericytes | 1 | 2018 | 292 | 0.030 |
Why?
|
Bicycling | 1 | 2017 | 176 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8641 | 0.030 |
Why?
|
Urologic Surgical Procedures | 1 | 2018 | 310 | 0.030 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2002 | 608 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2019 | 865 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5324 | 0.030 |
Why?
|
Proteoglycans | 1 | 2018 | 802 | 0.030 |
Why?
|
Social Participation | 1 | 2017 | 183 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2005 | 2063 | 0.030 |
Why?
|
Lung | 1 | 2014 | 9989 | 0.030 |
Why?
|
Cell Nucleolus | 1 | 2015 | 156 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2019 | 759 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7468 | 0.030 |
Why?
|
Genome, Viral | 1 | 2018 | 658 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2005 | 2544 | 0.030 |
Why?
|
Virulence | 1 | 2018 | 1295 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 2015 | 251 | 0.030 |
Why?
|
Femur | 2 | 2011 | 1302 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2017 | 503 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 3731 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2011 | 9590 | 0.030 |
Why?
|
Gene Expression | 3 | 2015 | 7592 | 0.030 |
Why?
|
Reference Values | 2 | 2011 | 4920 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1005 | 0.030 |
Why?
|
Quality of Life | 2 | 2017 | 13300 | 0.030 |
Why?
|
Genotype | 2 | 2019 | 12959 | 0.030 |
Why?
|
Chronic Disease | 3 | 2015 | 9283 | 0.030 |
Why?
|
Desmin | 1 | 2013 | 99 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 607 | 0.030 |
Why?
|
National Health Programs | 1 | 2016 | 442 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2017 | 1837 | 0.030 |
Why?
|
Resorcinols | 1 | 2013 | 41 | 0.030 |
Why?
|
Malondialdehyde | 1 | 2013 | 112 | 0.030 |
Why?
|
Antigens | 1 | 2018 | 1447 | 0.030 |
Why?
|
Injections, Spinal | 1 | 2013 | 316 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1090 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2013 | 127 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12281 | 0.030 |
Why?
|
Breath Tests | 1 | 2014 | 297 | 0.030 |
Why?
|
Anions | 1 | 2012 | 137 | 0.030 |
Why?
|
Mice, Inbred ICR | 1 | 2013 | 363 | 0.030 |
Why?
|
Cytochromes c | 1 | 2013 | 173 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2006 | 12412 | 0.030 |
Why?
|
Video Recording | 1 | 2017 | 957 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1080 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10829 | 0.030 |
Why?
|
Doxorubicin | 1 | 2019 | 2207 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 600 | 0.020 |
Why?
|
Cations | 1 | 2012 | 239 | 0.020 |
Why?
|
Static Electricity | 1 | 2012 | 261 | 0.020 |
Why?
|
Fatty Acids | 1 | 2020 | 1805 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 859 | 0.020 |
Why?
|
Triage | 1 | 2018 | 982 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2013 | 346 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2016 | 1375 | 0.020 |
Why?
|
Limit of Detection | 1 | 2012 | 280 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2011 | 5797 | 0.020 |
Why?
|
Research Design | 2 | 2017 | 6181 | 0.020 |
Why?
|
Occupational Diseases | 1 | 2020 | 1484 | 0.020 |
Why?
|
DNA, Viral | 1 | 2018 | 2195 | 0.020 |
Why?
|
Isoxazoles | 1 | 2013 | 230 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2013 | 576 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1902 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1591 | 0.020 |
Why?
|
Lumbar Vertebrae | 2 | 2011 | 1867 | 0.020 |
Why?
|
Metabolome | 1 | 2018 | 976 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2014 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2013 | 428 | 0.020 |
Why?
|
Lipoxins | 1 | 2014 | 418 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 2018 | 982 | 0.020 |
Why?
|
Hemiplegia | 1 | 2011 | 136 | 0.020 |
Why?
|
Mucous Membrane | 1 | 2014 | 657 | 0.020 |
Why?
|
Marital Status | 1 | 2012 | 432 | 0.020 |
Why?
|
Nitrobenzenes | 1 | 2010 | 66 | 0.020 |
Why?
|
Immunoblotting | 1 | 2014 | 1649 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3160 | 0.020 |
Why?
|
Egtazic Acid | 1 | 2010 | 169 | 0.020 |
Why?
|
Butadienes | 1 | 2010 | 107 | 0.020 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2011 | 200 | 0.020 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2013 | 423 | 0.020 |
Why?
|
Sciatic Nerve | 1 | 2013 | 612 | 0.020 |
Why?
|
Ribonucleotide Reductases | 1 | 2010 | 76 | 0.020 |
Why?
|
Referral and Consultation | 2 | 2013 | 3598 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2013 | 1849 | 0.020 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2010 | 132 | 0.020 |
Why?
|
Caspases | 1 | 2013 | 878 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2019 | 2167 | 0.020 |
Why?
|
Workflow | 1 | 2014 | 851 | 0.020 |
Why?
|
Benzamides | 1 | 2015 | 1369 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3605 | 0.020 |
Why?
|
Cyclin B | 1 | 2009 | 104 | 0.020 |
Why?
|
Multifactorial Inheritance | 1 | 2017 | 1351 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 871 | 0.020 |
Why?
|
Microscopy | 1 | 2014 | 881 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1790 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2017 | 1395 | 0.020 |
Why?
|
Seasons | 1 | 2015 | 1523 | 0.020 |
Why?
|
Protein Kinase C-alpha | 1 | 2009 | 113 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2013 | 675 | 0.020 |
Why?
|
Calcaneus | 1 | 2010 | 141 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6361 | 0.020 |
Why?
|
Antioxidants | 1 | 2017 | 1668 | 0.020 |
Why?
|
Tissue Donors | 1 | 2018 | 2314 | 0.020 |
Why?
|
CDC2 Protein Kinase | 1 | 2009 | 213 | 0.020 |
Why?
|
Chelating Agents | 1 | 2010 | 384 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2596 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2009 | 819 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 409 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2414 | 0.020 |
Why?
|
Muscles | 1 | 2013 | 1581 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2013 | 1166 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2016 | 1843 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5498 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2010 | 796 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1972 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2012 | 2509 | 0.020 |
Why?
|
Arsenic | 1 | 2011 | 357 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 943 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2811 | 0.020 |
Why?
|
Mouth Mucosa | 1 | 2010 | 426 | 0.020 |
Why?
|
Cyclin D | 1 | 2007 | 72 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2015 | 2003 | 0.020 |
Why?
|
Oncogene Protein v-akt | 1 | 2007 | 129 | 0.020 |
Why?
|
Fatty Liver | 1 | 2013 | 777 | 0.020 |
Why?
|
Reaction Time | 1 | 2013 | 2075 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2009 | 401 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2009 | 15680 | 0.020 |
Why?
|
Intestine, Small | 1 | 2013 | 1207 | 0.020 |
Why?
|
Prospective Studies | 3 | 2018 | 54263 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2015 | 1977 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2009 | 695 | 0.020 |
Why?
|
Herpes Simplex | 1 | 2010 | 477 | 0.020 |
Why?
|
Immediate-Early Proteins | 1 | 2009 | 449 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2013 | 2897 | 0.020 |
Why?
|
CpG Islands | 1 | 2011 | 1221 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 1408 | 0.020 |
Why?
|
Neuropeptides | 1 | 2011 | 941 | 0.020 |
Why?
|
Lasers | 1 | 2010 | 952 | 0.020 |
Why?
|
DNA Damage | 1 | 2015 | 2442 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2013 | 1861 | 0.020 |
Why?
|
Infant | 2 | 2020 | 36030 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2013 | 936 | 0.020 |
Why?
|
Exercise | 1 | 2022 | 5783 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2007 | 380 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2018 | 3061 | 0.020 |
Why?
|
Pregnancy | 1 | 2006 | 29725 | 0.020 |
Why?
|
Treatment Failure | 1 | 2011 | 2646 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2013 | 4625 | 0.010 |
Why?
|
Algorithms | 1 | 2005 | 13967 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2007 | 642 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2010 | 995 | 0.010 |
Why?
|
Luciferases | 1 | 2006 | 716 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2010 | 1731 | 0.010 |
Why?
|
Single-Cell Analysis | 1 | 2015 | 2368 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14396 | 0.010 |
Why?
|
DNA Copy Number Variations | 1 | 2013 | 2008 | 0.010 |
Why?
|
Length of Stay | 1 | 2018 | 6472 | 0.010 |
Why?
|
Body Height | 1 | 2010 | 1570 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2014 | 5201 | 0.010 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2006 | 717 | 0.010 |
Why?
|
Spin Labels | 1 | 2005 | 336 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2013 | 3207 | 0.010 |
Why?
|
HeLa Cells | 1 | 2009 | 3105 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 4494 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2013 | 2052 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4109 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15687 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2009 | 2698 | 0.010 |
Why?
|
RNA, Nuclear | 1 | 2002 | 30 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2006 | 1531 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8449 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2009 | 1614 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2005 | 698 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 3023 | 0.010 |
Why?
|
Retinoblastoma Protein | 1 | 2005 | 671 | 0.010 |
Why?
|
Aspirin | 1 | 2014 | 3365 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10183 | 0.010 |
Why?
|
Epilepsy | 1 | 2016 | 3267 | 0.010 |
Why?
|
Drug Design | 1 | 2006 | 1062 | 0.010 |
Why?
|
Keratins | 1 | 2002 | 497 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2753 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5793 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2006 | 3086 | 0.010 |
Why?
|
Software | 1 | 2014 | 4420 | 0.010 |
Why?
|
Sulfonamides | 1 | 2010 | 1973 | 0.010 |
Why?
|
Molecular Weight | 1 | 2002 | 2186 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 2002 | 900 | 0.010 |
Why?
|
Epithelium | 1 | 2004 | 1605 | 0.010 |
Why?
|
Postoperative Period | 1 | 2005 | 1821 | 0.010 |
Why?
|
Protons | 1 | 2005 | 1113 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12602 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15766 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26168 | 0.010 |
Why?
|
Brain | 1 | 2005 | 26912 | 0.010 |
Why?
|
Pyridines | 1 | 2010 | 2877 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10552 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2002 | 1633 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 8058 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5640 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 2002 | 1075 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2003 | 1490 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3774 | 0.010 |
Why?
|
Hospitalization | 1 | 2015 | 10761 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22025 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4923 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17766 | 0.010 |
Why?
|
RNA, Viral | 1 | 2002 | 2837 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2002 | 3491 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2004 | 8945 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2002 | 9196 | 0.000 |
Why?
|